Audenet et al. [50] demonstrated that the risk of bladder recurrence after UTUC is significantly associated with mutations in FGFR3, KDM6A, CCND1, and TP53. This evidence concerns the gene KDM6A and renal pelvis/ureter urothelial carcinoma.